Praxis Precision Medicines
PRAX
PRAX
248 hedge funds and large institutions have $8.69B invested in Praxis Precision Medicines in 2025 Q4 according to their latest regulatory filings, with 115 funds opening new positions, 86 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% more funds holding
Funds holding: 151 → 248 (+97)
0.66% more ownership
Funds ownership: 117.18% → 117.84% (+0.66%)
8% less call options, than puts
Call options by funds: $219M | Put options by funds: $238M
Holders
248
Holding in Top 10
24
Calls
$219M
Puts
$238M
Top Buyers
| 1 | +$245M | |
| 2 | +$234M | |
| 3 | +$88.7M | |
| 4 |
Barclays
London,
United Kingdom
|
+$84.6M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$81.4M |
Top Sellers
| 1 | -$262M | |
| 2 | -$187M | |
| 3 | -$92.4M | |
| 4 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$72.2M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$58.1M |
